Skip to main content

RT @doctorRBC: 2022 ASAS-EULAR Recommendations of AxSpA management 1) NSAIDs still first line 2) Analgesics/opioids cont

Nov 12, 2022 5:03 pm
Social Author Name
Robert B Chao, MD
Tweet Content
2022 ASAS-EULAR Recommendations of AxSpA management 1) NSAIDs still first line 2) Analgesics/opioids contraindicated 3) TNFi, IL-17i first line bDMARDs, followed by JAKinibs 4) Tapering but not discontinuation of bDMARDs in sustained remission Abs#0542 @RheumNow #ACR22 https://t.co/ffaN2fMc3v
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×